Exploring the role of hemodilution in the inverse association between obesity and testosterone concentrations in men
- PMID: 40249461
- DOI: 10.1007/s42000-025-00656-0
Exploring the role of hemodilution in the inverse association between obesity and testosterone concentrations in men
Abstract
Purpose: This study aims to explore the inverse correlation between obesity and testosterone concentrations in men, with a particular focus on the role of hemodilution in this association. The research question addressed is whether hemodilution, due to increased plasma volume (PV), contributes to the lower testosterone concentrations observed in obese men.
Methods: We conducted a retrospective analysis using three datasets with sample sizes of 86, 134, and 446 participants, respectively. Multivariable linear regression models were used to examine the changes in PV, testosterone concentration, and mass across BMI categories, adjusting for age in each dataset and in the pooled data.
Results: The study demonstrated a significant inverse correlation between BMI groups and testosterone concentrations across the three datasets, as well as in the pooled data (beta coefficients: -0.024, -0.045, -0.040, -0.043; P < 0.001). Despite this, total testosterone mass remained stable (P > 0.05), suggesting that hemodilution, rather than a reduction in testosterone production, may account for the lower testosterone concentrations in obesity. Adjusted testosterone concentrations for obese participants were calculated using a formula that accounts for the increased PV.
Conclusion: Our findings suggest that hemodilution, associated with increased PV in obesity, is a significant factor contributing to the lower testosterone concentrations in obese men. This has implications for the diagnosis and treatment of testosterone deficiency in obesity and underscores the need for adjusted reference ranges. Further research is necessary to validate these findings and to explore their clinical implications.
Keywords: Hemodillution; Obesity; Testosterone.
© 2025. The Author(s), under exclusive licence to Hellenic Endocrine Society.
Conflict of interest statement
Declarations. Ethics approval: This study was approved by the Institutional Review Board of Taihu Rehabilitation Hospital of Jiangsu Province and was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent: Given the retrospective nature of this study involving analysis of existing data, the requirement for informed consent was waived by the Institutional Review Board. The data were anonymized and de-identified prior to analysis to ensure confidentiality and protect the privacy of the individuals involved. Conflict of interest: The authors declare that they have no conflict of interest.
Similar articles
-
Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.Prostate. 2017 Apr;77(5):466-470. doi: 10.1002/pros.23285. Epub 2016 Dec 19. Prostate. 2017. PMID: 27990661 Clinical Trial.
-
Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1731-4. doi: 10.1158/1055-9965.EPI-12-0589. Epub 2012 Jul 31. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22850805
-
Hemodilution and Serum Progesterone Regulation in Males with Obesity.J Inflamm Res. 2025 Jun 5;18:7235-7241. doi: 10.2147/JIR.S525354. eCollection 2025. J Inflamm Res. 2025. PMID: 40491786 Free PMC article.
-
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.JAMA. 2007 Nov 21;298(19):2275-80. doi: 10.1001/jama.298.19.2275. JAMA. 2007. PMID: 18029831
-
Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics.Hum Reprod. 2013 Dec;28(12):3178-87. doi: 10.1093/humrep/det379. Epub 2013 Oct 15. Hum Reprod. 2013. PMID: 24129611
References
-
- Khodamoradi K, Khosravizadeh Z, Seetharam D, Mallepalli S, Farber N, Arora H (2022) The role of leptin and low testosterone in obesity. Int J Impot Res 34(7):704–713. https://doi.org/10.1038/s41443-022-00534-y - DOI - PubMed
-
- Giagulli VA, Castellana M, Carbone MD, Pelusi C, Ramunni MI, De Pergola G et al (2020) Weight loss more than glycemic control May improve testosterone in obese type 2 diabetes mellitus men with hypogonadism. Andrology 8(3):654–662. https://doi.org/10.1111/andr.12754 - DOI - PubMed
-
- Van de Velde F, Bekaert M, Hoorens A, Geerts A, T’Sjoen G, Fiers T et al (2020) Histologically proven hepatic steatosis associates with lower testosterone levels in men with obesity. Asian J Androl 22(3):252–257. https://doi.org/10.4103/aja.aja_68_19 - DOI - PubMed
-
- Wei D, Hou J, Liu X, Zhang L, Wang L, Liu P et al (2021) Interaction between testosterone and obesity on hypertension: a population-based cross-sectional study. Atherosclerosis 330:14–21. https://doi.org/10.1016/j.atherosclerosis.2021.06.906 - DOI - PubMed
-
- Riachy R, McKinney K, Tuvdendorj DR (2020) Various factors May modulate the effect of exercise on testosterone levels in men. J Funct Morphol Kinesiol 5(4):81. https://doi.org/10.3390/jfmk5040081 - DOI - PubMed - PMC
Grants and funding
LinkOut - more resources
Full Text Sources